Picture of Metacrine logo

MTCR — Metacrine News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Metacrine Inc expected to post a loss of 25  cents a share - Earnings Preview

* Metacrine Inc  MTCR.OQ   MTCR.O  is expected to show no
change
in quarterly revenue when it reports  results on August 10
(estimated). 
    * ​Refinitiv's mean analyst estimate for Metacrine Inc is
for a
loss of 25 cents per share. For the same quarter last year, the
company reported a loss of 59 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Metacrine
Inc is
$1​, above​ its last closing price of $0.50. ​​​

This summary was machine generated August 9 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Metacrine

See all news